Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

This study has been completed.
National Cancer Institute (NCI)
Eisai Inc.
Information provided by (Responsible Party):
Roswell Park Cancer Institute Identifier:
First received: August 22, 2012
Last updated: January 10, 2014
Last verified: January 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2013
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)